The reverse stock split will reduce the number of shares from ~69.06M to ~7.67M.
The company also announced preliminary Q2 results and expects sales of ~$2.3M, +70% Y/Y; product revenues increased 90% over the same period.
Nephros reiterated previous guidance for FY19 revenue of $8.5M - $9.5M
Now read: Avantor: Solid Business, Too Much Debt »
Subscribe for full text news in your inbox